TFFP - TFF Pharmaceuticals

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• TFF Pharmaceuticals down 22%, prices $5M offering
• TFF Pharmaceuticals GAAP EPS of -$0.14 beats by $0.06, revenue of $0.33M beats by $0.23M
• TFF Pharmaceuticals Q2 Earnings Preview
• TFF Pharma wins nearly $3M grant to develop universal flu shot
• TFF Pharmaceuticals GAAP EPS of -$0.19 beats by $0.01
• TFF Pharmaceuticals reports Q4 results
• TFF Pharma appoints Harlan Weismanas permanent chief executive officer
• TFF Pharmaceuticals names Zamaneh Mikhak as chief medical officer
• TFF Pharmaceuticals announces leadership transition
• TFF Pharma slips 22% on $10.68M public offering
• TFF Pharmaceuticals tumbles 25% after hours on proposed stock offering
• TFF Pharmaceuticals down after Q3 results as plans for Phase 2 data readouts confirmed
• TFF Pharmaceuticals GAAP EPS of -$0.29 beats by $0.04, revenue of $0.09M
• TFF Pharma plunges 39% after updating timeline for Phase 2 data readouts
• TFF Pharmaceuticals GAAP EPS of -$0.34 misses by $0.02, revenue of $28M
• TFF Pharmaceuticals expands R&D operations with new Austin facility
• TFF Pharmaceuticals GAAP EPS of -$0.33 beats by $0.05, revenue of $0.07M beats by $0.02M
• TFF Pharmaceuticals Q1 Earnings Preview
• TFF Pharma posts early-stage data for Niclosamide Inhalation Powder in COVID-19
• TFF Pharmaceuticals GAAP EPS of -$1.25 misses by $0.12, revenue of $0.09M misses by $0.59M